To include your compound in the COVID-19 Resource Center, submit it here.

Sanofi discontinues vaccine

Sanofi (Euronext:SAN; NYSE:SNY) said it is discontinuing development of its late-stage Clostridium difficile vaccine (ACAM-CDIFF) after an

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE